Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study

Bone Marrow Transplantation
M Díez-CampeloJ F San Miguel

Abstract

The aim was to analyze quality-of-life (QOL) during the first year post transplant in 47 patients undergoing reduced-intensity conditioning (RIC) allotransplantation, and to compare these with a similar subgroup of patients receiving autologous stem cell transplantation (ASCT). We used self-reported questionnaires. Each answer scored from 0 (not at all) to 4 (very much), with higher scores indicating worse functioning. Mean value of physical categories among RIC transplants ranged between 1.23 and 0.77 indicating that patients scored very low for physical symptoms. Patients undergoing ASCT had higher scores in questionnaires performed early after transplant and then gradually improved (P < 0.001). Overall, when we compared physical functioning scores, allo-RIC did significantly better (P = 0.049). Nevertheless, while allo-RIC scores were significantly better for the first three questionnaires, ASCT patients did better in the last two questionnaires. These findings are in accordance with the toxicities observed in both subgroups which are lower in the RIC group early after transplant. No significant differences were observed between either subgroup for any of the functional, social/ family, psychological distress and satisfactio...Continue Reading

References

Jan 1, 1988·British Journal of Cancer·M L SlevinW M Gregory
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J Hjermstad, S Kaasa
Jun 1, 1995·British Journal of Cancer·M A AndrykowskiP J Henslee-Downey
Dec 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C SebbanD Maraninchi
Mar 24, 1994·The New England Journal of Medicine·J O Armitage
Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F CellaJ Brannon
Jan 31, 1998·Bone Marrow Transplantation·M A AndrykowskiP J Henslee-Downey
Sep 11, 1998·Bone Marrow Transplantation·C S NeitzertJ Avery
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J HjermstadS Kaasa
Sep 21, 2000·British Journal of Haematology·S ChiodiA Bacigalupo
Feb 17, 2001·Psycho-oncology·S M Johnson VickbergW H Redd
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A SuredaUNKNOWN Grupo Español de Linformas/Transplante Autólogo de Médula Osea Spanish Cooperative Group
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T L KissH A Messner
Dec 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M D CaballeroE Conde

❮ Previous
Next ❯

Citations

Mar 7, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Margaret F BevansSusan Marden
Dec 22, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Annemarie M J BraamseKaren L Syrjala
May 5, 2009·Seminars in Oncology Nursing·Nonniekaye Shelburne, Margaret Bevans
Apr 26, 2013·European Journal of Haematology·Henriett JanicsákGábor Gazdag
Nov 4, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G VelikovaUNKNOWN EORTC Quality of Life Group
Apr 22, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Heather S L JimOxana Palesh
Aug 5, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Qingshan LiYaming Wei
Mar 3, 2015·Bone Marrow Transplantation·R Reshef, D L Porter
Oct 22, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·William A WoodSergio A Giralt
Aug 20, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Heather S L JimStephanie J Lee
Nov 1, 2016·Journal of Cancer Survivorship : Research and Practice·Peter EsserAnja Mehnert
Apr 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jesse R FannKaren L Syrjala
Dec 23, 2017·Bone Marrow Transplantation·Ashley M NelsonPaul B Jacobsen
Sep 18, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Matthias NaegeleSabina De Geest
Apr 2, 2021·Transplantation and Cellular Therapy·P Connor JohnsonAreej El-Jawahri
Jul 29, 2021·World Journal of Transplantation·Henrietta JanicsákGábor Gazdag

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.